Health care was the leading sector for several years, but when the market stumbled this past summer it was not able to recover. Currently, many areas within the sector show long-term breakdowns on the charts and are on the verge of ending corrective bounces. Health care products maker Abbott Laboratories (NYSE: ABT) is a good example, and thanks to the market’s sell-off to open the year, it has already broken down again. We’ll start with the big picture by looking at the weekly chart, which shows a 25% drop from mid-July to late September. To call that… Read More
Health care was the leading sector for several years, but when the market stumbled this past summer it was not able to recover. Currently, many areas within the sector show long-term breakdowns on the charts and are on the verge of ending corrective bounces. Health care products maker Abbott Laboratories (NYSE: ABT) is a good example, and thanks to the market’s sell-off to open the year, it has already broken down again. We’ll start with the big picture by looking at the weekly chart, which shows a 25% drop from mid-July to late September. To call that a mere correction would be wrong; although calling it a bear market for reaching the 20% loss threshold would be just as wrong. To me, this was a serious break that ended a four-year bull market. After such a move, we’d expect the stock to lick its wounds for a while, but Abbott had the good fortune of a broader market that came roaring out of its own decline. However, the S&P 500 was down “only” 12% over the same span, which is far more palatable in what at the time could still be considered a healthy… Read More